These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21846893)

  • 1. Letter by Santos et al regarding article, "Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease".
    Santos MT; Moscardo A; Vallés J
    Circ Cardiovasc Interv; 2011 Aug; 4(4):e31; author reply e32. PubMed ID: 21846893
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
    Bliden KP; Tantry US; DiChiara J; Gurbel PA
    Circ Cardiovasc Interv; 2011 Apr; 4(2):118-20. PubMed ID: 21505165
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
    Angiolillo DJ; Bernardo E; Capodanno D; Vivas D; Sabaté M; Ferreiro JL; Ueno M; Jimenez-Quevedo P; Alfonso F; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2010 Mar; 55(11):1139-46. PubMed ID: 20223369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of aspirin resistance in type 2 diabetes.
    Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
    J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease.
    Dillinger JG; Drissa A; Sideris G; Bal dit Sollier C; Voicu S; Manzo Silberman S; Logeart D; Drouet L; Henry P
    Am Heart J; 2012 Oct; 164(4):600-606.e1. PubMed ID: 23067920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes.
    Addad F; Chakroun T; Elalamy I; Abderazek F; Chouchene S; Dridi Z; Gerotziafas GT; Hatmi M; Hassine M; Gamra H
    Int J Hematol; 2010 Sep; 92(2):296-301. PubMed ID: 20725815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.
    Capranzano P; Ferreiro JL; Ueno M; Capodanno D; Dharmashankar K; Darlington A; Desai B; Tello-Montoliu A; Rollini F; Angiolillo DJ
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):42-9. PubMed ID: 22431415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin as antiplatelet agent in diabetes: Cons.
    Mannucci PM
    Eur J Intern Med; 2010 Jun; 21(3):154-6. PubMed ID: 20493413
    [No Abstract]   [Full Text] [Related]  

  • 12. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
    Spectre G; Arnetz L; Östenson CG; Brismar K; Li N; Hjemdahl P
    Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.
    Mortensen SB; Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Res; 2010 Oct; 126(4):e318-22. PubMed ID: 20451957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes.
    Bethel MA; Harrison P; Sourij H; Sun Y; Tucker L; Kennedy I; White S; Hill L; Oulhaj A; Coleman RL; Holman RR
    Diabet Med; 2016 Feb; 33(2):224-30. PubMed ID: 26043186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin as antiplatelet agent in diabetes. PROS-.
    Davì G; Santilli F
    Eur J Intern Med; 2010 Jun; 21(3):149-53. PubMed ID: 20493412
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
    Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
    Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor aspirin response in diabetic patients presenting with acute coronary syndromes: results using a near patient test.
    Amoah V; Smallwood A; Worrall AP; Lovatt T; Armesilla AL; Nevill AM; Cotton JM
    Thromb Res; 2011 Aug; 128(2):196-9. PubMed ID: 21543109
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter by Gasparovic et al regarding article, "Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial".
    Gasparovic H; Petricevic M; Biocina B
    Circulation; 2011 Aug; 124(6):e193; author reply e195-6. PubMed ID: 21824930
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
    Angiolillo DJ; Capranzano P; Goto S; Aslam M; Desai B; Charlton RK; Suzuki Y; Box LC; Shoemaker SB; Zenni MM; Guzman LA; Bass TA
    Eur Heart J; 2008 Sep; 29(18):2202-11. PubMed ID: 18567918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: DiChiara et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.
    Klein PS
    Diabetes; 2008 May; 57(5):e10; author reply e11. PubMed ID: 18443367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.